GAP-43 and MAP2, via increasing the expression of ATP/GTP binding protein-like 4 (AGBL4), promote neuronal differentiation of cholinergic neurons in AD (Baskerville et al. 2008). Here, MAP2 is linked to Alzheimer disease.